DRUG · Mapped RxNorm record
raltegravir
Normalized identity: raltegravir View linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Safety Study of Raltegravir in HIV/HCV Co-infected Patients
NCT01225705
Study summary
ClinicalTrials.govSafety Study of Raltegravir in HIV/HCV Co-infected Patients
Design: INTERVENTIONAL · Status: WITHDRAWN · Phase: PHASE4
Loading study purpose, treatment groups and outcomes…
View the complete registry record, eligibility and contacts at ClinicalTrials.gov
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Unmapped registry intervention
Atazanavir/ritonavir
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Advertisement
Conditions
HIVunresolved
Hepatitis Cunresolved
Interventions
raltegravirDRUG · verified · RxNorm: raltegravir
Sponsors & collaborators
University Hospital, Bonnlead sponsor
Dr. Axel Baumgarten, Berlincollaborator
Dr. Christoph Stephan, Frankfurt/Mcollaborator
Dr. Stefan Esser, Essencollaborator
Dr. Keikawus Arastéh, Berlincollaborator
Prof. Dr. Hans-Jürgen Stellbrink, Hamburgcollaborator
Dr. Thomas Lutz, Frankfurt/Mcollaborator
Dr. Jörg Gölz , Berlincollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01225705 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.